HK Stock Market Move | WESTCHINACEMENT (02233) rose more than 6% in early trading. The company has reached a strategic cooperation with the hydropower and electrical contractor, jointly expanding emerging markets in Africa, Central Asia, and other regions.
Western Cement (02233) rose more than 6% in early trading, as of the time of writing, it has risen by 5.25%, closing at HK$3.41 with a trading volume of HK$155 million.
WESTCHINACEMENT (02233) rose over 6% in early trading, and as of the time of writing, it was up 5.25% at 3.41 Hong Kong dollars, with a trading volume of 155 million Hong Kong dollars.
On the news front, on October 14, WESTCHINACEMENT signed a strategic cooperation agreement with Hydropower Three Bureau. The future cooperation will focus on three main directions: first, to build a localized supply chain to serve projects such as the Shaanxi Pumped Storage Power Station; second, to promote synergy between "overseas projects + local production capacity", combining Hydropower Three Bureau's engineering advantages in Guinea, the Philippines, Central Asia, etc., with WESTCHINACEMENT's production capacity in Africa and Central Asia; and third, to jointly build a cooperation platform to deepen cooperation in specific projects in Angola, Congo (Kinshasa), Mozambique, etc., and contribute to the high-quality development of new era energy construction and building materials industry.
Changjiang previously pointed out that it expects overseas expansion to bring greater medium-term resilience. The African cement market is large with high prosperity and profitability far exceeding that of domestic markets. It is a new blue ocean market for domestic companies going global. The company currently has several projects under construction/planning in the African market, and it expects these projects to contribute to larger performance increments once they are put into operation one by one.
Related Articles

HK Stock Market Move | ASCLETIS-B (01672) has risen by more than 4% Company has completed communication with the National Medical Products Administration before submitting a new drug application for Dendyphothalascet.

LVMH returns to growth trajectory! Edouard Evin, the mastermind behind the "Louis Vuitton: A Journey Beyond" exhibition, becomes the key driving force.

UBS: Expects AIA (01299) to accelerate growth in new business value in the third quarter. Rated "Buy".
HK Stock Market Move | ASCLETIS-B (01672) has risen by more than 4% Company has completed communication with the National Medical Products Administration before submitting a new drug application for Dendyphothalascet.

LVMH returns to growth trajectory! Edouard Evin, the mastermind behind the "Louis Vuitton: A Journey Beyond" exhibition, becomes the key driving force.

UBS: Expects AIA (01299) to accelerate growth in new business value in the third quarter. Rated "Buy".

RECOMMEND